category 
Health Law Advisor
JANUARY 13, 2022
The proposed decision, which is subject to public comments that are due to CMS by February 10, 2022, does not endorse nationwide Medicare coverage for these drugs. The FDA’s determination does not mandate Medicare coverage for Aduhelm. The Medicare Part B program would not cover the drugs in any other setting.
Health Law Advisor
MAY 2, 2023
The Centers for Medicare & Medicaid Services (“CMS”) is using its annual rulemaking process to update the CMS payment system rules for fiscal year (“FY”) 2024 as a mechanism to advance health equity systematically across various CMS payment programs. health system.” [9] health system.” [9]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare Law Blog
MAY 16, 2022
On April 29, 2022 , the Centers for Medicare and Medicaid Services (“CMS”), issued the final rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs (the “Final Rule”). With a few exceptions, the Final Rule is a wholesale codification of the proposed rule.
HIT Consultant
NOVEMBER 24, 2022
For the first time, all hearing aids will fall under two categories: prescription hearing aids and OTC hearing aids. Health plans could, for example, consider covering OTC hearing devices as part of the hearing benefits package provided to their Medicare Advantage plan members. million U.S. million have moderate hearing loss.
NY Health Law
FEBRUARY 13, 2024
On January 9, 2024, the federal Centers for Medicare and Medicaid Services (CMS) finally approved New York State’s 1115 waiver amendment to establish the New York Health Equity Reform (NYHER) Program. The waiver amendment authorizes up to $2.2 The actual Medicaid Hospital Global Budget Model to be used remains to be approved by CMS.
Healthcare IT Today
APRIL 10, 2023
Uncle Roy’s story is not unique; the individual behaviors that people with chronic conditions perform on a daily basis are the most important determinant of future health outcomes. Over the next several years, we will focus on defining and leading a new category in healthcare. trillion in annual health care costs.
Healthcare Law Blog
MARCH 17, 2022
On Thursday, March 16, the Office of the Inspector General for the Department of Health and Human Services (“OIG”) issued OIG Advisory Opinion (“AO”) No. 22-05 , relating to subsidization of certain Medicare cost-sharing obligations in the context of a clinical trial involving medical devices (the “Proposed Arrangement”).
Expert insights. Personalized for you.
52 
Let's personalize your content